Women who use an oral contraceptive might want to consider using a back-up method after starting a weight loss drug.

Weight-loss medications like Ozempic and Mounjaro are not as effective in a “real-world” setting, according to a new study.

The two products accounted for about 48% of Eli Lilly's most recent quarterly sales and drove most of the top-line growth.

Millions of Americans use GLP-1s, and many have relied on versions produced by compounding pharmacies because of the high monthly costs for brand names like Mounjaro and Zepbound.

Revenue have seized a significant amount of weight-loss drugs and other medical products purchased online recently ...